So to get the IA approval and cut the number of patients down, etc, doesn't the FDA have to consider all the current data, including the deaths at that time? Or not? Anyone? I just assume the would, and therefore viewed the deaths as not a problem.
You can be sure somebody knew about it and was unloading their position into all the positive news last week. Guaranteed. So when did they know? Big funds keep tabs on all the patients, I'm sure. They don't leave anything to chance. They probably started selling before Rosa even knew.